Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
Clinical trial NCT03934814 · COMPLETED
Trial details
- NCT number
- NCT03934814
- Sponsor
- I-Mab Biopharma US Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2023-01-10
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.